New Delhi, August 7: US pharma giant Johnson and Johnson's single-dose COVID-19 vaccine Janssen has received approval for Emergency Use Authorization (EUA) in India, informed Union Health Minister Mansukh Mandaviya on Saturday. "India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has 5 EUA vaccines. This will further boost our nation's collective fight against COVID-19," tweeted the Minister. India’s Cumulative COVID-19 Vaccination Coverage Crosses 50 Crore-Mark, Nearly 50 Lakh Vaccine Doses Administered in Past 24 Hours.

Johnson and Johnson on Friday informed it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine Janssen to the Government of India. The pharma company had stated that it is an important milestone that paves the way to bringing the single-dose COVID-19 vaccine to the people of India, and the rest of the world, through a collaboration with Biological E. Limited. Delta Variant Levels Same Regardless of COVID-19 Vaccine, Finds UK Study.

Tweet By Mansukh Mandaviya: 

The pharma company's statement read, "The EUA submission is based on topline efficacy and safety data from the Phase 3 clinical trial ENSEMBLE, which demonstrated our single-shot vaccine was 85 per cent effective in preventing severe disease across all regions studied, and showed protection against COVID-19 related hospitalization and death, beginning 28 days after vaccination."

India crossed a significant milestone of administering 50 crore vaccine doses under a nationwide vaccination drive. With 49,55,138 vaccinations in the last 24 hours, India has so far administered a total of 50,10,09,609 doses.

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)